284 related articles for article (PubMed ID: 37538397)
1. Identification and characterization of putative biomarkers and therapeutic axis in Glioblastoma multiforme microenvironment.
Kumari S; Kumar P
Front Cell Dev Biol; 2023; 11():1236271. PubMed ID: 37538397
[TBL] [Abstract][Full Text] [Related]
2. Emerging trends in post-translational modification: Shedding light on Glioblastoma multiforme.
Kumari S; Gupta R; Ambasta RK; Kumar P
Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):188999. PubMed ID: 37858622
[TBL] [Abstract][Full Text] [Related]
3. UBE2S, a novel substrate of Akt1, associates with Ku70 and regulates DNA repair and glioblastoma multiforme resistance to chemotherapy.
Hu L; Li X; Liu Q; Xu J; Ge H; Wang Z; Wang H; Wang Z; Shi C; Xu X; Huang J; Lin Z; Pieper RO; Weng C
Oncogene; 2017 Feb; 36(8):1145-1156. PubMed ID: 27593939
[TBL] [Abstract][Full Text] [Related]
4. The Chromatin-Oxygen Sensor Gene
Drongitis D; Verrillo L; De Marinis P; Orabona P; Caiola A; Turitto G; Alfieri A; Bruscella S; Gentile M; Moriello V; Sannino E; Di Muccio I; Costa V; Miano MG; de Bellis A
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142158
[TBL] [Abstract][Full Text] [Related]
5. Genes of the Ubiquitin Proteasome System Qualify as Differential Markers in Malignant Glioma of Astrocytic and Oligodendroglial Origin.
Vriend J; Klonisch T
Cell Mol Neurobiol; 2023 May; 43(4):1425-1452. PubMed ID: 35896929
[TBL] [Abstract][Full Text] [Related]
6. Histone acetyltransferase 1 (HAT1) acetylates hypoxia-inducible factor 2 alpha (HIF2A) to execute hypoxia response.
Kumar N; Mondal M; Arathi BP; Sundaresan NR; Somasundaram K
Biochim Biophys Acta Gene Regul Mech; 2023 Mar; 1866(1):194900. PubMed ID: 36410688
[TBL] [Abstract][Full Text] [Related]
7. An update on the molecular biology of glioblastoma, with clinical implications and progress in its treatment.
Verdugo E; Puerto I; Medina MÁ
Cancer Commun (Lond); 2022 Nov; 42(11):1083-1111. PubMed ID: 36129048
[TBL] [Abstract][Full Text] [Related]
8. UBE2S and UBE2C confer a poor prognosis to breast cancer
Guo Y; Chen X; Zhang X; Hu X
Front Oncol; 2023; 13():992233. PubMed ID: 36860312
[TBL] [Abstract][Full Text] [Related]
9. Post-translational modifications of FDA-approved plasma biomarkers in glioblastoma samples.
Petushkova NA; Zgoda VG; Pyatnitskiy MA; Larina OV; Teryaeva NB; Potapov AA; Lisitsa AV
PLoS One; 2017; 12(5):e0177427. PubMed ID: 28493947
[TBL] [Abstract][Full Text] [Related]
10. Integration of RNA-Seq and proteomics data identifies glioblastoma multiforme surfaceome signature.
Syafruddin SE; Nazarie WFWM; Moidu NA; Soon BH; Mohtar MA
BMC Cancer; 2021 Jul; 21(1):850. PubMed ID: 34301218
[TBL] [Abstract][Full Text] [Related]
11. miR-140 targeting CTSB signaling suppresses the mesenchymal transition and enhances temozolomide cytotoxicity in glioblastoma multiforme.
Ho KH; Cheng CH; Chou CM; Chen PH; Liu AJ; Lin CW; Shih CM; Chen KC
Pharmacol Res; 2019 Sep; 147():104390. PubMed ID: 31398406
[TBL] [Abstract][Full Text] [Related]
12. The immunosuppressive microenvironment and immunotherapy in human glioblastoma.
Zhang X; Zhao L; Zhang H; Zhang Y; Ju H; Wang X; Ren H; Zhu X; Dong Y
Front Immunol; 2022; 13():1003651. PubMed ID: 36466873
[TBL] [Abstract][Full Text] [Related]
13. The E3 ubiquitin ligase HUWE1 acts through the N-Myc-DLL1-NOTCH1 signaling axis to suppress glioblastoma progression.
Yuan Y; Wang LH; Zhao XX; Wang J; Zhang MS; Ma QH; Wei S; Yan ZX; Cheng Y; Chen XQ; Zou HB; Ge J; Wang Y; Zhang X; Cui YH; Luo T; Bian XW
Cancer Commun (Lond); 2022 Sep; 42(9):868-886. PubMed ID: 35848447
[TBL] [Abstract][Full Text] [Related]
14. Pan-cancer analysis of ASB3 and the potential clinical implications for immune microenvironment of glioblastoma multiforme.
Mu L; Han Z; Yu S; Wang A; Chen D; Kong S; Gu Y; Xu L; Liu A; Sun R; Long Y
Front Immunol; 2022; 13():842524. PubMed ID: 36618381
[TBL] [Abstract][Full Text] [Related]
15. Chemerin enhances mesenchymal features of glioblastoma by establishing autocrine and paracrine networks in a CMKLR1-dependent manner.
Wu J; Shen S; Liu T; Ren X; Zhu C; Liang Q; Cui X; Chen L; Cheng P; Cheng W; Wu A
Oncogene; 2022 May; 41(21):3024-3036. PubMed ID: 35459783
[TBL] [Abstract][Full Text] [Related]
16.
Shi Y; Jiang J; Cui Y; Chen Y; Dong T; An H; Liu P
DNA Cell Biol; 2021 Jan; 40(1):93-100. PubMed ID: 33181035
[TBL] [Abstract][Full Text] [Related]
17. EIF4A3-induced circular RNA MMP9 (circMMP9) acts as a sponge of miR-124 and promotes glioblastoma multiforme cell tumorigenesis.
Wang R; Zhang S; Chen X; Li N; Li J; Jia R; Pan Y; Liang H
Mol Cancer; 2018 Nov; 17(1):166. PubMed ID: 30470262
[TBL] [Abstract][Full Text] [Related]
18. UBE2S exerts oncogenic activities in urinary bladder cancer by ubiquitinating TSC1.
Tang H; Fang T; Ji M; Wang JP; Song LL; Zhang QY; Wu JS
Biochem Biophys Res Commun; 2021 Nov; 578():7-14. PubMed ID: 34520980
[TBL] [Abstract][Full Text] [Related]
19. Ubiquitin chain-elongating enzyme UBE2S activates the RING E3 ligase APC/C for substrate priming.
Martinez-Chacin RC; Bodrug T; Bolhuis DL; Kedziora KM; Bonacci T; Ordureau A; Gibbs ME; Weissmann F; Qiao R; Grant GD; Cook JG; Peters JM; Wade Harper J; Emanuele MJ; Brown NG
Nat Struct Mol Biol; 2020 Jun; 27(6):550-560. PubMed ID: 32393902
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of ubiquitin-conjugating enzyme gene ube2h and siRNA-mediated regulation on targeting p53 in turbot, Scophthalmus maximus.
Guo X; Ma A; Huang Z; Wang XA; Yang K; Liu Z; Zhang J; Cui W
J Therm Biol; 2021 Jul; 99():102938. PubMed ID: 34420605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
